Provided by Tiger Trade Technology Pte. Ltd.

Quest Diagnostics

238.36
-1.9416-0.81%
Volume:314.33K
Turnover:75.29M
Market Cap:26.31B
PE:25.31
High:243.72
Open:242.68
Low:238.08
Close:240.30
52wk High:247.19
52wk Low:171.18
Shares:110.37M
Float Shares:110.00M
Volume Ratio:0.53
T/O Rate:0.29%
Dividend:3.32
Dividend Rate:1.39%
EPS(TTM):9.42
EPS(LYR):8.75
ROE:14.60%
ROA:6.40%
PB:3.50
PE(LYR):27.24

Loading ...

Quest Diagnostics Inc - Sees FY2026 Capital Expenditures About $550 Mln

THOMSON REUTERS
·
Apr 21

Quest Diagnostics Outlook FY EPS USD 9.58-9.78

THOMSON REUTERS
·
Apr 21

Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

THOMSON REUTERS
·
Apr 21

U.S. Earnings Preview: Before Market Open April 21

Dow Jones
·
Apr 21

What to Watch in the Day Ahead - Tuesday, April 21

Reuters
·
Apr 21

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Centessa Pharmaceuticals (CNTA) and Perspective Therapeutics (CATX)

TIPRANKS
·
Apr 20

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 20

Quest Diagnostics Inc expected to post earnings of $2.35 a share - Earnings Preview

Reuters
·
Apr 17

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 17

City of Hope evaluates Quest’s Haystack MRD test in multi-cancer clinical trials

Reuters
·
Apr 16

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 15

Baird Adjusts Price Target on Quest Diagnostics to $224 From $219, Maintains Neutral Rating

MT Newswires Live
·
Apr 14

Earning Preview: Quest Diagnostics Q1 revenue is expected to increase by 7.47%, and institutional views are broadly constructive

Earnings Agent
·
Apr 14

Assessing Quest Diagnostics (DGX) Valuation As Long Term Returns Draw Fresh Investor Attention

Simply Wall St.
·
Apr 11

Quest Diagnostics Is Maintained at In-Line by Evercore ISI Group

Dow Jones
·
Apr 08

Quest Diagnostics target cut, added to ‘Tactical Outperform’ list at Evercore

TIPRANKS
·
Apr 08

Evercore ISI Adjusts Price Target on Quest Diagnostics to $210 From $220, Maintains In Line Rating

MT Newswires Live
·
Apr 08

Quest Diagnostics announces annual shareholder meeting

Reuters
·
Apr 07

PRECIOUS-Gold slips as markets assess prospects of Iran ceasefire

Reuters
·
Mar 26

How Investors May Respond To Quest Diagnostics (DGX) Expanding Blood-Based Cancer Screening And Boardroom Expertise

Simply Wall St.
·
Mar 22